{
  "documents": [
    {
      "id": "cluster_2_doc1",
      "content": "Claim submitted by Mountain Peak Neurology for patient Gerald Kovac (ID PT-8872-3A) for specialized cognitive therapy sessions during 02/2024. Documentation includes referral from Dr. Emilia Torres at Summit Valley Hospital and prior authorization number PA-6653-9B. Patient diagnosed with early-onset Lewy body dementia and REM sleep behavior disorder.",
      "metadata": {
        "format": "claim_form"
      }
    },
    {
      "id": "cluster_2_doc2",
      "content": "Research protocol memo from Colorado Neurodegenerative Institute detailing participation criteria for study CNI-228 (Lewy spectrum disorders). Includes Gerald Kovac's screening results showing unusual treatment response pattern to cholinesterase inhibitors. Study coordinator: Lydia Marnell (lydia.marnell@cni-research.co), IRB approval expires 10/15/2025.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_2_doc3",
      "content": "Internal audit of neurocognitive claims at Blue Horizon Insurance identified 43% increase in pre-authorization requests for Lewy body dementia treatments in Q1 2024. Notable case: PT-8872-3A required three peer-to-peer reviews due to combination therapy protocol. Regional manager: Arjun Patel (303-555-0187).",
      "metadata": {
        "format": "audit_report"
      }
    },
    {
      "id": "cluster_2_doc4",
      "content": "News article in Boulder Medical Times: 'Breakthrough in Dementia Care Coverage' mentions new state mandate requiring coverage for multi-modal therapies. Features patient story referencing Mountain Peak Neurology case with unusual sleep study findings (patient declined to be named but matches clinical details from PT-8872-3A).",
      "metadata": {
        "format": "news_article"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_2",
    "cluster_risk": "HIGH",
    "content_summary": "Patient Gerald Kovac's complex neurological care journey intersecting with specialized claims processing, clinical research participation, and policy changes regarding dementia treatments",
    "person": {
      "entities": [
        [
          "Gerald Kovac",
          "NAME"
        ],
        [
          "PT-8872-3A",
          "PATIENT_ID"
        ],
        [
          "early-onset Lewy body dementia",
          "MEDICAL_CONDITION"
        ],
        [
          "REM sleep behavior disorder",
          "MEDICAL_CONDITION"
        ],
        [
          "PA-6653-9B",
          "NON_PERSONAL_ID"
        ],
        [
          "CNI-228",
          "NON_PERSONAL_ID"
        ],
        [
          "02/2024",
          "EVENT_DATE"
        ],
        [
          "Mountain Peak Neurology",
          "PROVIDER"
        ],
        [
          "unusual treatment response pattern",
          "UNIQUE_FACT"
        ]
      ]
    },
    "questions": [
      {
        "q": "Which two neurological conditions does Gerald Kovac (PT-8872-3A) have according to his Mountain Peak Neurology claim?",
        "a": "Early-onset Lewy body dementia and REM sleep behavior disorder.",
        "sources": [
          "cluster_2_doc1"
        ],
        "type": "specific"
      },
      {
        "q": "What percentage increase in pre-authorization requests for Lewy body dementia treatments did Blue Horizon's audit find in Q1 2024?",
        "a": "43% increase in pre-authorization requests.",
        "sources": [
          "cluster_2_doc3"
        ],
        "type": "general"
      },
      {
        "q": "What study number and unusual clinical feature are documented for Gerald Kovac's participation in Colorado Neurodegenerative Institute research?",
        "a": "Study CNI-228 showed unusual treatment response to cholinesterase inhibitors.",
        "sources": [
          "cluster_2_doc1",
          "cluster_2_doc2"
        ],
        "type": "specific"
      },
      {
        "q": "How do the Boulder Medical Times article and audit report collectively highlight changes in dementia care coverage?",
        "a": "New state mandates require multi-modal therapy coverage following increased pre-authorization requests.",
        "sources": [
          "cluster_2_doc3",
          "cluster_2_doc4"
        ],
        "type": "general"
      }
    ]
  }
}